NEJM stands by its criticism of Vioxx study

被引：6

作者：

Tanne, JH

机构：

来源：

BRITISH MEDICAL JOURNAL | 2006年 / 332卷 / 7540期

关键词：

D O I：

10.1136/bmj.332.7540.505-a

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：505 / 505

页数：1

共 50 条

[1] NEJM editor gives pretrial evidence in Vioxx case
Tanne, JH
[J]. BRITISH MEDICAL JOURNAL, 2006, 332 (7536): : 255 - 255
[2] NEJM corrects its study on rofecoxib
Mayor, S
[J]. BRITISH MEDICAL JOURNAL, 2006, 333 (7557): : 12 - 12
[3] Scientific publishing -: Echoing other cases, NEJM says Vioxx safety data withheld
Couzin, J
[J]. SCIENCE, 2005, 310 (5755) : 1755 - 1755
[4] THE CRITICISM STANDS
ABRAHAMSSON, B
[J]. SOCIOLOGISK FORSKNING, 1981, 18 (02) : 73 - 74
[5] NEJM reckons with its past
Brainard, Jeffrey
[J]. SCIENCE, 2023, 382 (6675) : 1095 - 1095
[6] PHARMACOVIGILANCE AND THE CASE STUDY OF VIOXX
Krancberg, A. N.
Chmielewska, M.
Hermanowski, T. R.
[J]. VALUE IN HEALTH, 2012, 15 (07) : A322 - A322
[7] Merck's careful study of Vioxx
Mayer, Theodore V. H.
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (07): : 1068 - 1069
[8] VIRUS CANCER PROGRAM - REVIEW PANEL STANDS BY CRITICISM
CULLITON, BJ
[J]. SCIENCE, 1974, 184 (4133) : 143 - 145
[9] Merck's careful study of Vioxx - Reply
Maron, Barry J.
Hauser, Robert G.
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (07): : 1069 - 1069
[10] Introducing NEJM Knowledge plus and Its Adaptive Personalized Learning
McMahon, Graham T.
Drazen, Jeffrey M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (17): : 1648 - 1649